These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Expression of protein kinase C-substrate mRNAs in the basal ganglia of adult and infant macaque monkeys. Higo N; Oishi T; Yamashita A; Murata Y; Matsuda K; Hayashi M J Comp Neurol; 2006 Dec; 499(4):662-76. PubMed ID: 17029258 [TBL] [Abstract][Full Text] [Related]
24. The striopallidal system: Its implication in motor disorders. Poirier LJ; Parent A; Roberge AG Pathobiol Annu; 1975; 5():339-67. PubMed ID: 812038 [No Abstract] [Full Text] [Related]
25. Ascending pathways from substantia nigra to basal ganglia. Petrovický P Acta Univ Carol Med (Praha); 1973; 19(7-8):489-500. PubMed ID: 4806320 [No Abstract] [Full Text] [Related]
26. Neural responses in multiple basal ganglia regions during spontaneous and treadmill locomotion tasks in rats. Shi LH; Luo F; Woodward DJ; Chang JY Exp Brain Res; 2004 Aug; 157(3):303-14. PubMed ID: 15067433 [TBL] [Abstract][Full Text] [Related]
27. Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease. Labandeira-Garcia JL; Rodriguez-Pallares J; Dominguez-Meijide A; Valenzuela R; Villar-Cheda B; Rodríguez-Perez AI Mov Disord; 2013 Sep; 28(10):1337-42. PubMed ID: 23925977 [TBL] [Abstract][Full Text] [Related]
28. The unbearable lightness of the extrapyramidal system. de Oliveira-Souza R; Tovar-Moll F J Hist Neurosci; 2012 Jul; 21(3):280-92. PubMed ID: 22724489 [TBL] [Abstract][Full Text] [Related]
29. [Quantitative studies of neurons of the substantia nigra and basal ganglia in parkinsonism]. Togi H; Ogawa M; Yamanouchi H; Tomonaga M; Kameyama M Rinsho Shinkeigaku; 1976 Apr; 16(4):311-8. PubMed ID: 986268 [No Abstract] [Full Text] [Related]
31. A HYPOTHESIS CONCERNING A SITE OF ACTION OF TRANQUILIZING DRUGS AND THE SIGNIFICANCE OF ASSOCIATED EXTRAPYRAMIDAL MOTOR PHENOMENA. VENNING GR J New Drugs; 1963; 3(6):351-5. PubMed ID: 14113558 [No Abstract] [Full Text] [Related]
34. [Subcortical structures of the brain and the behavior of white rats]. Gambarian LS; Garibian AA; Koval' IN; Sarkisian ZhS; Sarkisov GT Zh Vyssh Nerv Deiat Im I P Pavlova; 1984; 34(3):459-64. PubMed ID: 6475296 [TBL] [Abstract][Full Text] [Related]
35. Comparative cerebral and basal ganglia biopsy studies in extrapyramidal disorders. ROIZIN L; HOUSEPIAN E; POOL JL; ASAO H Trans Am Neurol Assoc; 1962; 87():132-5. PubMed ID: 13982492 [No Abstract] [Full Text] [Related]
36. [Secondary degeneration of substantia nigra following massive basal ganglia infarction]. Ohara S; Kondo K; Kagoshima M; Yanagisawa N Rinsho Shinkeigaku; 1989 Nov; 29(11):1352-6. PubMed ID: 2625020 [TBL] [Abstract][Full Text] [Related]
37. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA]. Levin SL Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303 [No Abstract] [Full Text] [Related]
38. Basal ganglia and thalamic input from neurons located within the ventral tier cell cluster region of the substantia nigra pars compacta in the rat. Cebrián C; Prensa L J Comp Neurol; 2010 Apr; 518(8):1283-300. PubMed ID: 20151360 [TBL] [Abstract][Full Text] [Related]
39. The effects of multiple thalamic and/or pallidal lesions in extrapyramidal disease. NASHOLD BS; OTTOLENGHI AD Surg Forum; 1960; 11():379-81. PubMed ID: 13727838 [No Abstract] [Full Text] [Related]
40. Nigrotomy in treatment of extrapyramidal diseases. Zapletal B Acta Neurochir (Wien); 1965; 13(3):388-92. PubMed ID: 5882614 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]